Submitted for Publication: May 24, 2012; final revision received September 25, 2012; accepted October 11, 2012.
Published Online: March 28, 2013. doi:10.1001/jamaophthalmol.2013.1686
Conflict of Interest Disclosures: None reported.
Group Members: The Tema Eye Survey Study Group members are as follows: Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida: Jagadeesh Bandi, MD, MPH, Donald L. Budenz, MD, MPH, William Feuer, MS, Joyce Schiffman, MS. National Institute for Health Research Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital, London, United Kingdom: Keith Barton, MD, Tunde Peto, MD, PhD, Ferenc Sallo, Graham Hay-Smith, MRCS(Ed), MRCOphth, Winnie Nolan, MD. Duke University Eye Center, Durham, North Carolina: Leon Herndon, MD. The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland: James Tielsch, PhD, Julia Whiteside-de Vos, MD, MPH*. Department of Ophthalmology, Stanford University, Palo Alto, California: Peter Egbert, MD, Hanna Kim, MD. Unit of Ophthalmology, University of Ghana Medical School, Ghana, Africa: Stephen Akafo, MD. International Aid, Spring Lake, Michigan: Faye Kragt, COMS. Department of Ophthalmic Epidemiology, Institute of Ophthalmology, University College London, London, United Kingdom: Pak Sang Lee, MPhil. Tema Christian Eye Centre, Tema, Ghana: Shine Amaglo, Maureen Armarh, Steven Boakye, Frank Boateng, Michaela Clemens, MS, Patience Dadzie, RN, Paulina Darkenu, Ernest Elikem, Sarah Mechta, BA, George Wood.
*Dr Whiteside-de Vos was not affiliated with The Johns Hopkins Bloomberg School of Public Health while conducting study activities in Ghana.
Funding/Support: This study was supported by grants awarded to International Aid, Spring Lake, Michigan, from Pfizer, Inc, and the Allergan Foundation; unrestricted core grant NIH P30 EY014801 awarded to the University of Miami by the National Institutes of Health, Bethesda, Maryland; an unrestricted grant to Research to Prevent Blindness, Inc, New York, New York; a Mid-Career Physician Scientist Award from the American Glaucoma Society (Dr Budenz); and National Eye Institute Training grant T32 EY 07127, Clinical Trials Training Program in Vision Research (Dr Whiteside-de Vos).
Additional Contributions: Pak Sang Lee, MPhil, of the National Institute for Health Research Biomedical Research Center for Ophthalmology, UCL Institute of Ophthalmology, and Moorfields Eye Hospital, London, United Kingdom, provided technical training and support on this study, and Emily West Gower, PhD, of Wake Forest University (previously of The Johns Hopkins University) provided advice regarding adjustment of prevalence rates.